Prostate-specific membrane antigen and uses thereof

Details Prostate-specific membrane antigen and uses thereof Prostate-specific membrane antigen and uses thereof

2006-05-02

2006-05-02

Kunz, Gary (Department: 1647)

Chemistry: molecular biology and microbiology

Measuring or testing process involving enzymes or...

Involving nucleic acid

C536S024100, C536S024200, C536S024300, C536S024310

Reexamination Certificate

active

07037647

ABSTRACT:
This invention provides an isolated mammalian nucleic acid molecule encoding an alternatively spliced prostate-specific membrane (PSM′) antigen. This invention provides an isolated nucleic acid molecule encoding a prostate-specific membrane antigen promoter. This invention provides a method of detecting hematogenous micrometastic tumor cells of a subject, and determining prostate cancer progression in a subject.

REFERENCES:
patent: 4554101 (1985-11-01), Hopp
patent: 5162504 (1992-11-01), Horoszewicz
patent: 5538866 (1996-07-01), Israeli et al.
patent: 5672592 (1997-09-01), Jackson et al.
patent: 5773292 (1998-06-01), Bander
patent: 5795877 (1998-08-01), Jackson et al.
patent: 5804602 (1998-09-01), Slusher et al.
patent: 5863536 (1999-01-01), Jackson et al.
patent: 5880112 (1999-03-01), Jackson et al.
patent: 5902817 (1999-05-01), Jackson et al.
patent: 5935818 (1999-08-01), Israeli et al.
patent: 5939258 (1999-08-01), Croce et al.
patent: 5962521 (1999-10-01), Jackson et al.
patent: 5968915 (1999-10-01), Jackson et al.
patent: 5981209 (1999-11-01), Slusher et al.
patent: 6011021 (2000-01-01), Slusher et al.
patent: 6017903 (2000-01-01), Slusher et al.
patent: 6025344 (2000-02-01), Jackson et al.
patent: 6025345 (2000-02-01), Jackson et al.
patent: 6046180 (2000-04-01), Jackson et al.
patent: 6054444 (2000-04-01), Jackson et al.
patent: 6107090 (2000-08-01), Bander
patent: 6121252 (2000-09-01), Jackson et al.
patent: 6136311 (2000-10-01), Bander
patent: 6150508 (2000-11-01), Murphy et al.
patent: 6271245 (2001-08-01), Jackson et al.
patent: 6288046 (2001-09-01), Jackson et al.
patent: 6348464 (2002-02-01), Jackson et al.
patent: 6372726 (2002-04-01), Slusher et al.
patent: 6384022 (2002-05-01), Jackson et al.
patent: 6395718 (2002-05-01), Slusher et al.
patent: 6413948 (2002-07-01), Slusher et al.
patent: 6452044 (2002-09-01), Jackson et al.
patent: 6458775 (2002-10-01), Jackson et al.
patent: 6479471 (2002-11-01), Jackson et al.
patent: 6569432 (2003-05-01), Israeli et al.
patent: 6586623 (2003-07-01), Tsukamoto et al.
patent: 6649163 (2003-11-01), Bander
patent: 2002/0013295 (2002-01-01), Slusher et al.
patent: 2002/0015704 (2002-02-01), Bander
patent: 2002/0019430 (2002-02-01), Jackson et al.
patent: 2002/0044459 (2002-04-01), Tsubota et al.
patent: 2002/0151503 (2002-10-01), Slusher et al.
patent: 2003/0007974 (2003-01-01), Nanus et al.
patent: 2003/0017965 (2003-01-01), Slusher et al.
patent: 2003/0031673 (2003-02-01), Bander
patent: 2003/0064912 (2003-04-01), Slusher et al.
patent: 2003/0083374 (2003-05-01), Jackson et al.
patent: 2003/0105088 (2003-06-01), Tsukamoto et al.
patent: 2003/0216468 (2003-11-01), Tsukamoto et al.
patent: 2004/0001846 (2004-01-01), Israeli et al.
patent: 2004/0024188 (2004-02-01), Murphy et al.
patent: 0173951 (1986-12-01), None
patent: WO9409820 (1994-05-01), None
patent: WO9735616 (1997-10-01), None
patent: WO9947554 (1999-09-01), None
Fabe, et al.,JBC, vol. 266, pp. 10743-10747, 1990.
Solin et al.,Biochimica Biophysics Acta, vol. 1048, pp. 72-77, 1990.
Corr, J.G. et al., (1994) “Prostate Specific Membrane Antigen (PSM) Expression in Orthotopically Implanted Human Prostate Cancer Cells in Nude Mice Slows Tumor Growth and Metastatic Potential” J Urol 151:492A.
Israeli, R.S. et al., (1994) “Localization of the Prostate Specific Membrane Antigen (PSM) to the Putative Metastasis-Suppressor Region on Human Chromosome 11” Proceedings of the American Association for Cancer Research 35:271.
Israeli, R.S. et al., (1993) “Characterization of the Prostate-Specific Membrane Antigen (PSM)” Cancer Research 34:255.
Israeli, R.S. et al., (1993) “Molecular Cloning and Characterization of a Prostate-Specific Membrane Antigen” J Urol. 149:471A.
Israeli, R.S. et al., (1992) “Purification and Molecular Cloning of a New Prostate-Specific Antigen” Cancer Research 33:3564.
Translation of Abstract of EP 0 173 951.
Tortora, G.J., et al., (1989)Microbiology An Introduction,Benjamin/Cummings Publishing Co., 423-426, 471.
Stites, D.P., et al., (1991)Basic and Clinical Immunology,Appleton & Lange, 229-251.
Rose, N.R., et al., (1986)Manual of Clinical Laboratory Immunology,American Society for Microbiology, 89-109.
Paul, W.E. (1989)Fundamental Immunology,Raven Press, 628-629, 647-651.
Gately, M.K. et al., (1992) “Regulation of Human Cytololytic Lymphocyte Responses by Interleukin-12”,Cellular Immunology143:381-385.
Rossi, M. C. & Zetter, B.R., (1992) “Selective Stimulation of Prostatic Carcinoma Cell Proliferation by Transferrin”,PNAS89:6197-6201.
Sambrook, J. et al., (1989)Molecular Cloning, A Laboratory Manual,Cold Spring Harbor Laboratory Press, 16.1-16.81.
Schneider , C. et al, (1984) “Primary Structure of Human Transferrin Receptor Deduced from the mRNA sequence”,Nature311:675-678.
U.S. Appl. No. 09/357,704, filed Jul. 20, 1999, Bander.
U.S. Appl. No. 09/357,707, filed Jul. 20, 1999, Bander.
U.S. Appl. No. 09/357,708, filed Jul. 20, 1999, Bander.
U.S. Appl. No. 09/357,709, filed Jul. 20, 1999, Bander.
U.S. Appl. No. 09/357,710, filed Jul. 20, 1999, Bander.
U.S. Appl. No. 09/929,546, filed Jul. 20, 1999, Bander.
U.S. Appl. No. 09/929,665, filed Jul. 20, 1999, Bander.
U.S. Appl. No. 09/561,462, filed Jul. 20, 1999, Murphy et al.
U.S. Appl. No. 09/561,502, filed Jul. 20, 1999, Murphy et al.
U.S. Appl. No. 09/724,630, filed Jul. 20, 1999, Murphy et al.
Su, S.L., et al. (1995) Cancer Research, 55, 7:1441-1443 (Exhibit 1).
Abdel-Nabi, H., et al. (1992) “Monoclonal Antibodies and Radioimmunoconjugates in the Diagnosis and Treatment of Prostate Cancer”, Seminars on Urology 127: 45-54.
Axelrod, H. R., et al. (1968) “Preclinical Results and Human Immunohitochemical Studies With 90Y-CYT-356: A New Prostate Cancer Therapeutic Agent” AUA 87th Annual Meeting, May 10-14, 1992.
Carter, B.H. And Coffey, D.S. (1990) “The Prostate: An Increasing Medical Problem” The Prostate 16:39-48.
Feng, Q., et al. (1991) “Purification and Biochemical Characterization of the 7E11-C5 Prostate Carcinoma-Associated Antigen”, Proceedings of the American Association for Cancer Research 32:239.
Chang Chawnshang, et al. (1988) “Structural Analysis of Complementary DNA and Amino Acid Sequences of Human and Rat Androgen Receptors”, Proc. Natl Acad. Sci USA 85:7211-7215.
Culver, K.W., et al. (1992) “In Vivo Gene Transfer with Retoviral Vector-Producer Cells for Treatment of Experimental Brain Tumors”, Science 256:1150-1552.
Decensi, A., et al. (1991) “Phase II Study of the Pure Non-steroidal Antiandrogen Nilutamide in Prostatic Cancer”, Eur J Cancer 27:1100-1104.
Faber, P.W., et al. (1991) “Characterization of the Human Androgen Transcription Unit” The Journal of Biological Chemistry 266:10743-10749.
Fey, Martin F., et al. (1991) “The Polymerase Chain Reaction: A New Tool for the Detection of Minimal Residual Disease in Haematological Malignancies” Eur J Cancer 27:89-94.
Henttu, Pirkko and Vihko, Pirkko (1989) “cDNA Coding for the Entire Human Prostate Specific Antigen Shows High Homologies to the Human Tissue Kallikrein Genes” Biochemical and Biophysical Research Communications 160:903-910.
Horoszewicz, Julius S., et al. (1987) “Monoclonal Antibodies to a New Antigen Marker in Epithelial Prostatic Cells and Serum of Prostatic Cancer Patients” AntiCancer Research 7:927-936.
Huber, Brian E., et al. (1991) “Retroviral-mediated Gene Therapy for the Treatment of Hepatocellular Carcinoma: An Innovative Approach for Cancer Therapy” Proc. Natl. Acad. Sci. USA 88:8039-8043.
Israeli, Ron S., et al. (1994) “Expression of the Prostate Specific Membrane Antigen” Cancer Research 54:1807-1811.
Israeli, Ron S., et al. (1994) “Sensitive Nested Reverse Transcription Polymerase Chain Reaction Detection of Circulating Prostatic Tumor Cells: Comparison of Prostate-specific Membrane Antigen and Prostate-specific Antig

Affiliated with

Also associated with

Rating

Prostate-specific membrane antigen and uses thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Prostate-specific membrane antigen and uses thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Prostate-specific membrane antigen and uses thereof will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3622079